Ian Cox
About Ian Cox
Ian Cox Principal Investigator
Ian Cox currently holds the title of Principal Investigator. Throughout his career, he has collaborated extensively with academic partners on research projects that have been funded by both corporate and government grants. His role involves leading and managing various research phases, from feasibility studies to post-launch evaluations. Cox plays a crucial part in bridging the gap between clinicians and engineers, ensuring that clinical needs are translated into effective design specifications and outcomes.
Ian Cox Industry Experience
Ian Cox has 35 years of industry experience. He has a wealth of expertise in driving projects through all phases of clinical studies. Over his career, Cox has provided strategic direction and technical guidance, overseeing the growth and development of large technical teams. He has a specialized focus in taking products from conception through to post-launch, ensuring their success in the market.
Ian Cox Background and Product Design at Bausch + Lomb
Ian Cox has over 25 years of experience in product and optic design at Bausch + Lomb. Beginning as a Senior Research Optometrist in 1986, he was promoted to Research Fellow in 1998. From 2003 to 2006, he directed the Clinical and Scientific Affairs department. He became a Distinguished Research Fellow in 2006 and later served as the Director of Lens Design, Optics, and Advanced Tooling in 2010. Cox reached the Senior Executive level as a Bausch + Lomb Research Fellow in 2013. His work focused mainly on developing innovative products such as contact lenses, refractive surgery instruments, and intraocular lenses.
Ian Cox Achievements in Ophthalmology
Throughout his career, Ian Cox has been driven by a passion for advancing the field of ophthalmology. His innovative approaches have focused on improving products related to vision correction, such as contact lenses and intraocular lenses. By bridging the gap between clinicians and engineers, he has contributed significantly to developing designs that meet clinical needs. This synergy has led to improved patient outcomes and higher quality of life for those affected by vision impairments.